The patients took atorvastatin for 6 months or 12 months (10–80 mg/day, depending on baseline serum cholesterol levels) until their aminotransferase levels normalized or their liver density ...

Pfizer’s monopoly over the blockbuster cholesterol-reducing molecule atorvastatin, trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 ...

To meet predefined lowdensity lipoprotein-cholesterol ... attained in 62% of atorvastatin recipients and 6% of bezafibrate recipients, and triglyceride levels <200 mg/dL were achieved in 52% ...

Statins, including atorvastatin ... LDL-C level ≥ 70 mg/dL and < 190 mg/dL: High-intensity statin therapy should be initiated (Class I recommendation) if calculated 10-year ASCVD risk is ...

Low-density lipoprotein (LDL) cholesterol level was reduced to <80 mg/dL in the atorvastatin group and remained ... 125 mg/dL and 210 mg/dL after a 4-10 week period to wash out any previous ...